Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...
7don MSNOpinion
I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next
Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...
Axsome Therapeutics (NASDAQ:AXSM) executives highlighted accelerating commercial momentum, a near-term regulatory catalyst, ...
The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...
Add Yahoo as a preferred source to see more of our stories on Google. Brain scans of a person with Alzheimer's are seen in this conceptual image. (Getty Images) This story was originally published on ...
Alzheimer's disease is a kind of brain disease that progressively impairs thinking, behaviour, and memory. It is most prevalent in older adults, and people find it more difficult to carry out daily ...
'People in the later stages of dementia may behave out of character,' an organisation has warned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results